XML 105 R84.htm IDEA: XBRL DOCUMENT v3.8.0.1
BUSINESS SEGMENT INFORMATION (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Segment Reporting Information [Line Items]                      
Percentage of net revenues from the DIS business                 90.00% 90.00% 90.00%
Total net revenues $ 1,936 $ 1,931 $ 1,943 $ 1,899 $ 1,861 $ 1,885 $ 1,906 $ 1,863 $ 7,709 $ 7,515 $ 7,493
Total operating income                 1,165 1,277 1,399
Non-operating expenses, net                 (135) (191) (296)
Income before income taxes and equity in earnings of equity method investees                 1,030 1,086 1,103
Income tax expense                 (241) (429) (373)
Equity in earnings of equity method investees, net of taxes                 35 39 23
Net income 267 175 207 175 167 205 209 115 824 696 753
Less: net income attributable to noncontrolling interests 13 14 14 11 12 13 14 12 52 51 44
Net income attributable to Quest Diagnostics $ 254 $ 161 $ 193 $ 164 $ 155 $ 192 $ 195 $ 103 772 645 709
Depreciation and amortization                 270 249 304
Total capital expenditures                 252 293 263
Routine clinical testing services [Member]                      
Segment Reporting Information [Line Items]                      
Total net revenues                 4,309 4,179 4,078
Gene-based and esoteric (including advanced diagnostics) testing services [Member]                      
Segment Reporting Information [Line Items]                      
Total net revenues                 2,449 2,335 2,256
Anatomic pathology testing services [Member]                      
Segment Reporting Information [Line Items]                      
Total net revenues                 612 624 631
All other services [Member]                      
Segment Reporting Information [Line Items]                      
Total net revenues                 339 377 528
DIS business [Member]                      
Segment Reporting Information [Line Items]                      
Total net revenues                 7,370 7,138 6,965
Total operating income                 1,313 1,244 1,118
Depreciation and amortization                 189 170 212
Total capital expenditures                 219 264 243
All other operating segments [Member]                      
Segment Reporting Information [Line Items]                      
Total net revenues                 339 377 528
Total operating income                 52 64 110
Depreciation and amortization                 6 6 10
Total capital expenditures                 15 21 16
General corporate income (expenses), Net [Member]                      
Segment Reporting Information [Line Items]                      
Total operating income                 (200) (31) 171
Depreciation and amortization                 75 73 82
Total capital expenditures                 $ 18 $ 8 $ 4